Thermo Fisher Scientific Expands Clinical Research Laboratory in Wisconsin
2024年6月18日 - 9:15PM
ビジネスワイヤ(英語)
The PPD clinical research business' new
laboratory will enhance services in new and emerging therapeutic
areas, add 350 new jobs to region
The PPD clinical research business of Thermo Fisher Scientific
Inc., the world leader in serving science, today unveiled a new
clinical research laboratory building at its good manufacturing
practices (GMP) lab in Middleton, Wisconsin. The new
72,500-square-foot building increases the site’s chemistry,
manufacturing and control (CMC) analytical capabilities as part of
its clinical development and laboratory services focused on
improving health by helping customers deliver life-changing
medicines.
“As research in biopharmaceutical therapies continues to rapidly
expand, we are excited to expand our overall capacity and
capabilities in laboratory services to help our customers deliver
therapies that meet the highest quality and safety standards for
patients,” said Leon Wyszkowski, president, analytical services,
clinical research, Thermo Fisher Scientific. “We will continue to
support and empower our customers as they continue to discover,
develop and deliver new groundbreaking therapies. This $58 million
investment to expand the site is a testament to our dedication in
supporting Thermo Fisher’s Mission of making the world healthier,
cleaner and safer.”
The GMP site offers high-quality analytical services for small
molecules and biologics, including biopharmaceuticals, inhaled
pharmaceuticals and device testing, cell and gene therapy, protein
characterization and mass spectrometry analysis for all phases of
drug development. The latest addition to the GMP campus provides a
multi-use and flexible biosafety level 2 laboratory that includes a
purpose-built liquid chromatography-mass spectrometry and protein
characterization space, two large molecular suites with access
controlled pre- and post-amplification labs, and two large
general-use labs. The expansion will add up to 350 scientists and
laboratory support professionals to the almost 2,300 employees
working across the research campus.
Earlier this year, Thermo Fisher announced the addition of
biosafety testing to its GMP portfolio of services at the Middleton
facility. With the addition of this capability, as well as the
addition of the new building, the site offers a full complement of
end-to-end laboratory services.
“As Wisconsin’s biohealth sector continues to grow, so will our
workforce, our economic momentum, and our opportunities to build a
healthier, stronger state for all,” said Gov. Tony Evers. “This new
state-of-the-art facility will not only further advance our state’s
biosafety testing capabilities and create hundreds of jobs, but it
will also help protect consumers and improve patient health
outcomes across the state.”
In addition to GMP and bioanalytical labs in Middleton, Thermo
Fisher’s clinical research laboratory business includes
bioanalytical, biomarker and vaccine sciences labs in Richmond,
Virginia; a GMP lab in Athlone, Ireland; central labs and biomarker
operations in Brussels, Belgium, Highland Heights, Kentucky, and
Singapore; and bioanalytical, biomarker, vaccine sciences and
central labs in Suzhou, China.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue over $40 billion. Our Mission is to
enable our customers to make the world healthier, cleaner and
safer. Whether our customers are accelerating life sciences
research, solving complex analytical challenges, increasing
productivity in their laboratories, improving patient health
through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240617336374/en/
Media: Nadine Maeser media@ppd.com